Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. 1997

C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
Unità di valutazione tossicologica, Centro per lo Studio dei Tumori di Origine Ambientale (CSTA), Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

Intra- and interindividual variations of baseline frequencies of cytogenetic end points in lymphocytes of human populations have been reported by various authors. Personal characteristics seem to account for a significant proportion of this variability. Several studies investigating the role of age as a confounding factor in cytogenetic biomonitoring found an age-related increase of micronucleus (MN) frequency, whereas contradictory results were reported for chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs). We have quantitatively evaluated the effect of age on SCE, CA, and MN through the analysis of a population sample that included data from several biomonitoring studies performed over the last few decades in 12 Italian laboratories. The large size of the data set, i.e., more than 2000 tests for each end point, allowed us to estimate the independent effect of age, taking into account other covariates, such as sex, smoking habits, occupational exposure, and inter- and intralaboratory variability. A greater frequency of the mean standardized values by increasing of age was observed for all of the end points. A leveling off was evident in the last age classes in the trend of MN frequencies. Frequency ratios (FRs), which express the increase of the cytogenetic damage with respect to the first age classes, i.e., 1-19 years, were estimated using Poisson regression analysis after adjustment for the potential confounding factors and confirmed the increasing trend by age class for all three end points. The most dramatic increase was observed for MN, with a FR that approaches the value of 2 at the age class 50-59 (FR, 1.97; 95% confidence interval, 1.43-2.71) and remains substantially unchanged thereafter. The trend of FRs for CA is more homogeneous, with a constant rise even in the older classes, whereas the frequency of SCE increases with age to a lesser extent, reaching a plateau in the age class 40-49 and the maximum value of FR in the age class over 70 (FR, 1.14; 95% confidence interval, 1.07-1.23). In conclusion, our results point to an age-related increase of the chromosome damage in lymphocytes and emphasize the need to take into account the potential confounding effect of this variable in the design of biomonitoring studies based on chromosome damage.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004784 Environmental Monitoring The monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment (soil, air, and water), workplace, or in the bodies of people and animals present in that environment. Monitoring, Environmental,Environmental Surveillance,Surveillance, Environmental
D005260 Female Females

Related Publications

C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
November 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
September 1996, Mutation research,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
April 1989, Mutation research,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
March 1987, Mutation research,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
January 2002, Teratogenesis, carcinogenesis, and mutagenesis,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
January 1985, Hereditas,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
January 2009, Drug and chemical toxicology,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
January 1994, Yi chuan xue bao = Acta genetica Sinica,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
May 2002, Mutation research,
C Bolognesi, and A Abbondandolo, and R Barale, and R Casalone, and L Dalprà, and M De Ferrari, and F Degrassi, and A Forni, and L Lamberti, and C Lando, and L Migliore, and P Padovani, and R Pasquini, and R Puntoni, and I Sbrana, and M Stella, and S Bonassi
December 1987, Mutation research,
Copied contents to your clipboard!